1-23825368-C-T
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4BP6_Very_StrongBP7BS1BS2
The NM_000191.3(HMGCL):c.48G>A(p.Ala16Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00243 in 1,560,010 control chromosomes in the GnomAD database, including 37 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A16A) has been classified as Likely benign.
Frequency
Consequence
NM_000191.3 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HMGCL | NM_000191.3 | c.48G>A | p.Ala16Ala | synonymous_variant | 1/9 | ENST00000374490.8 | NP_000182.2 | |
HMGCL | NM_001166059.2 | c.48G>A | p.Ala16Ala | synonymous_variant | 1/7 | NP_001159531.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HMGCL | ENST00000374490.8 | c.48G>A | p.Ala16Ala | synonymous_variant | 1/9 | 1 | NM_000191.3 | ENSP00000363614.3 |
Frequencies
GnomAD3 genomes AF: 0.00871 AC: 1326AN: 152210Hom.: 17 Cov.: 32
GnomAD3 exomes AF: 0.00314 AC: 512AN: 162912Hom.: 12 AF XY: 0.00253 AC XY: 222AN XY: 87646
GnomAD4 exome AF: 0.00174 AC: 2456AN: 1407682Hom.: 21 Cov.: 32 AF XY: 0.00163 AC XY: 1136AN XY: 695540
GnomAD4 genome AF: 0.00874 AC: 1332AN: 152328Hom.: 16 Cov.: 32 AF XY: 0.00820 AC XY: 611AN XY: 74490
ClinVar
Submissions by phenotype
Deficiency of hydroxymethylglutaryl-CoA lyase Benign:4
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 28, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at